Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders

Conditions: Neurodevelopmental Disorders; Autism; Autism Spectrum Disorder; Fragile X Syndrome; Tuberous Sclerosis; 22Q11 Deletion Syndrome; 22Q11 Deletion; ADHD; Tic Disorders; Tourette Syndrome; Tourette Syndrome in Children; Tourette Syndrome in Adolescence; ADHD - Combined Type; ADHD Predominantly Inattentive Type; ADHD, Predominantly Hyperactive - Impulsive; Provisional Tic Disorder; Anxiety; Anxiety Disorders; Agoraphobia; Generalized Anxiety; Generalized Anxiety Disorder; Social Anxiety; Social Anxiety Disorder; Unspecified Anxiety Disorder; Other Specified Anxiety Disorders; Separation Anxiety Interventions: Drug: Sertraline; Other: Placebo Sponsors: Anagnostou, Evdokia, M.D.; Azrieli Foundation; Canadian Institutes of Health Research (CIHR); Ontario Brain Institute; Holland Bloorview Kids Rehabilitation Hospital; McMaster University; Western University; Queen ' s University; University of Alberta; Alberta Health services; St. Justine ' s Hospital; Dalhousie University; Unity Health Toronto; University of Toronto; The Hospital for Sick Children Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials